CNTG News and Press, Centogene N.V. From 06/01/21

World leader and trusted partner in rare diseases releases enhanced Whole Exome Sequencing (WES) solution to improve diagnosis in complex and unsolved patient cases NEW CentoXome® provides best-in-class clinical insights based on CENTOGENE’s unique rare disease-centric Bio...

Centogene N.V. (CNTG) to nominate Rene Just as Chief Financial Officer at the upcoming Annual General Meeting.Rene will join the company on June 1, 2021, to work closely through the transition with current CFO Richard Stoffelen, who has decided to leave the Company as of June 30, 2021. R...

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 26, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced the nomination of Rene Just as Chief Fina...

Centogene (CNTG) appointed entrepreneur and executive with 25+ years experience Dr. Michael Motz as Chief Commercial Officer, Pharmaceuticals, effective June 1.Most recently, he was Entrepreneur in Residence at BB Pureos Bioventures in Zurich, Switzerland."Michael bri...

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 18, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical...

Providing patients with genetic testing designed to accelerate the diagnosis and personalized treatment of Parkinson’s disease (PD) The Rostock International Parkinson's Disease (ROPAD) Study aims to characterize the genetics of PD to establish a better understanding of...

Database has grown to more than 465,000 analyzed patients, with more than 225,000 being linked to HPO terms Release includes increase of almost 19 million to over 31 million unique variants New features, including variant classification based on ACMG guidelines and strea...

More than half of patients with genetic diseases remain undiagnosed, even after performing Exome and Genome Sequencing By performing deep genetic analyses and Bio/Databank mining, CENTOGENE discovers six novel gene-disease associations and evidence supporting 31 candidate genes St...

Image source: The Motley Fool. Centogene N.V. (NASDAQ: CNTG) Q4 2020 Earnings Call Apr 15, 2021 , 8:00 a.m. ET Continue reading For further details see: Centogene N.V. (CNTG) Q4 2020 Earnings Call Transcript

Centogene N.V. (CNTG) Q4 2020 Earnings Conference Call April 15, 2021 8:00 A.M. ET Company Participants Lennart Streibel - Investor Relations Andrin Oswald - Chief Executive Officer Richard Stoffelen - Chief Financial Officer Conference Call Participants Erin Wright - Credit Suisse Alex Cogut...